Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RCT-01
- Development stage
- Preclinical
- Lead developer
- RepliCel Life Sciences
- Modality
- Cell Therapies
- Administration
- Intratendinous
01
Overview
RCT-01 is an autologous cell therapy developed by RepliCel Life Sciences for the treatment of chronic tendon injuries, specifically Achilles tendinosis. The therapy consists of type I collagen-expressing fibroblasts derived from the non-bulbar dermal sheath (NBDS) of a patient's own hair follicles. These cells are isolated, expanded, and then injected into the site of tendon injury under ultrasound guidance. The mechanism of action involves the production of cellular collagen to kick-start the healing process and promote tendon regeneration, addressing the underlying degeneration rather than just symptoms. Clinical data from Phase 1/2 trials have demonstrated safety and signals of efficacy in improving tendon structure, physical function, and pain scores.
- Other names
- hair follicle-derived fibroblastsnon-bulbar dermal sheath cellsNBDS cellsautologous fibroblasts
Beyond the preview
Go deeper on RCT-01.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RCT-01.